Daily Archives: September 15, 2022

Trump All but Calls For Another January 6 If Hes Indicted Over Classified Documents – Vanity Fair

Posted: September 15, 2022 at 10:13 pm

Something you might have noticed over the last several years is that Donald Trump is a big fan of violence. Not directly getting involved in violencehed never dirty his hands in that waybut inciting people to engage in it on his behalf, the most famous example being the time he incited an insurrection at the US Capitol that left multiple people dead. Which is why it was more than a little disturbing when he warned on Thursday that there would be big problems if he were indicted for hoarding top secret government documents at his house.

In an interview with conservative radio host Hugh Hewitt, Trump said that he didnt believe the people of the United States would stand for charges against him from the Justice Department, adding that such charges would lead to problems in this country, the likes of which perhaps weve never seen before. Asked exactly what he meant by problems, Trump continued to use coded language that few would find difficult to parse. I think theyd have big problems. Big problems, he said. I just dont think theyd stand for it. They will not sit still and stand for this ultimate of hoaxes.

Obviously, at no point in the interview did Trump literally tell his supporters to engage in violent acts if he is prosecuted, but thats probably because he knows he doesnt have to. While Trumps allies have insisted that he never explicitly told people to attack the Capitol on January 6, many of the rioters interpreted as much from his speech, as the ex-president encouraged his supporters to fight like hell. Asked by Hewitt how he would respond to legacy media calling him out for inciting violence this time around, Trump said: Thats not inciting. Im just saying what my opinion is. I dont think the people of this country would stand for it.

In the nearly month and a half since the FBI searched his Mar-a-Lago residence for classified documentsones that a Trump lawyer claimed had already been returnedthe ex-president has spent most of his time attacking the government, baselessly accusing federal agents of planting evidence at his house, and otherwise whipping his supporters into a misinformed frenzy. Unsurprisingly, there has reportedly been, per Politico, an uptick in threats against federal law enforcement in the aftermath of the Mar-a-Lago search, which the Senate Judiciary and Homeland Security committees were briefed on this week. It was stunning, the number of threats that have been cataloged since the August 8 search of Mar-a-Lago, Senate Judiciary chair Dick Durbin said, noting the armed man who showed up at an FBI field office in Ohio in the days following the raid. Its a much more dangerous environment because of the political statements made by some individuals since August 8its alarming to me. Specifically calling out Trump, he said: Inviting a mob to return to the streets is exactly what happened here on January 6, 2021. This president knew what he was doingand we saw the results. His careless, inflammatory rhetoric has its consequences.

Last month Attorney General Merrick Garland condemned the broadsides that right-wing commentators, GOP lawmakers, and supporters of the ex-president had been leveling at FBI agents since the raid. I will not stand by silently when their integrity is unfairly attacked, Garland said during a press conference. The men and women of the FBI and the Justice Department are dedicated, patriotic public servants. Every day they protect the American people from violent crime, terrorism, and other threats to their safety while safeguarding our civil rights. They do so at great personal sacrifice and risk to themselves. I am honored to work alongside them.

Trump, of course, had a long history of inciting violence even before January 6. In addition to telling rallygoers to knock the crap out of anyone who showed up to one of his events holding a tomato, hed also previouslyinstructedpolice officers to let suspects heads knock against the side of their squad cars;toldsupporters, in reference to a protester whod been ejected from an event, Id like to punch him in the face;fantasizedabout Second Amendment people preventing the appointment of liberal judges; andendorsed the assault of reporters.

Visit link:
Trump All but Calls For Another January 6 If Hes Indicted Over Classified Documents - Vanity Fair

Posted in Second Amendment | Comments Off on Trump All but Calls For Another January 6 If Hes Indicted Over Classified Documents – Vanity Fair

Could you pass the U.S. citizenship test?: There are 100 questions on the civics section of the U.S. citizenship test. Applicants are asked ten of…

Posted: at 10:13 pm

Angela Underwood

Jan Willem van Hofwege // Shutterstock

Passing the U.S. citizenship test is a vital step toward becoming an American citizen. To pass the civics portion of the test, an applicant must correctly answer six of up to 10 oral U.S. history and government-related questions administered by a U.S. citizen immigration services officer. The questions come from a pool of 100 possible questions.

The questions tell the story of how the 13 colonies fought against Great Britain in the American Revolutionary War; how the U.S. Constitution came to be; and how the federal government was formed by the founding fathers including Benjamin Franklin, George Washington, John Adams, and James Madison.

They also cover U.S. history through World Wars I and II, the Great Depression, the Vietnam War, the Cold War, and 9/11. Some questions require knowledge of the Democratic and Republican parties and the workings of the U.S. Congress.

After passing the test, paying a fee, and completing all other necessary steps and paperwork, applicants who were once considered foreigners become full-fledged American citizens under the U.S. Constitution. Once naturalized, new citizens are entitled to the full rights of a person born in the United States.

Stacker has compiled a list of the 100 questions and answers on the civics test and formatted them like a quiz in the following gallery. Think you can pass the test with flying colors? Read on to see just how tough the questions areand how solid your high school history class recall is. Kicking things off, here's the first question:

#1: What is the supreme law of the land?

You may also like: Your guide to the Cabinet of the United States

Daderot // Wikimedia Commons

Answer #1: The Constitution.

The U.S. Constitution, written in 1787 in the Pennsylvania State House, was ratified by the original 13 colonies in 1788 and went into full effect in 1789 when 38 delegates from each state signed the document. The master copy of the constitution, comprised of seven articles, is on display at the National Archives in Washington D.C.

Question #2: What does the Constitution do?

Ed Uthman // Flickr

Answer #2: Sets up the government; defines the government; protects basic rights of Americans.

The U.S. Constitution sets up the government into three branchesexecutive, legislative, and judicial. The executive branch consists of the U.S. president, the vice president, the Cabinet, and members of all federal agencies, departments, committees, and commissions. The legislative branch includes the U.S. Congress, which is made up of the Senate and House of Representatives. The judicial branch is the U.S. Supreme Court and other federal courts. The rights of American citizens are protected under government laws and by elected members, who must be of a certain age to serve.

Question #3: The idea of self-government is in the first three words of the Constitution. What are these words?

Pixabay

Answer #3: "We the people..."

All citizens of the U.S. are included in the first three words, "We the people," of the U.S. Constitution's preamble.

Question #4: What is an amendment?

Felman // Shutterstock

Answer #4: A change (to the Constitution); an addition (to the Constitution).

The U.S. Constitution has more than two dozen amendments, changes or additions to clarify its meaning and include provisions not included in the first draft. The changes to the original draft range widely. Notable amendments to the U.S. Constitution include the freedom of religion and speech, the right to bear arms, the abolition of slavery, and allowing African American men and all women to vote.

Question #5: What do we call the first 10 amendments to the Constitution?

Charles Haire // Shutterstock

Answer #5: The Bill of Rights.

The first 10 amendments to the U.S. Constitution, written by James Madison in 1791, are known as the Bill of Rights. The amendments were added to protect citizens, expand freedoms, and to limit government power. After several representatives objected to the 10 changes, a decision was made to place the Bill of Rights at the end of the document under Article VII, rather than directly editing the original text.

Question #6: What is one right or freedom from the First Amendment?

You may also like: Political Cartoons From The Last 100 Years

Anthony Correia // Shutterstock

Answer #6: Speech; religion; assembly; press; petition the government.

There are five fundamental rights in the First Amendment. The first two allow people the right to say and believe whatever they want; the third allows people to assemble peacefully; the fourth allows people the right to report the news without government censorship; and the fifth allows people the right not to be witnesses against themselves in a criminal case.

Question #7: How many amendments does the Constitution have?

Public Domain // goodfreephotos

Answer #7: 27

The 27 amendments to the U.S. Constitution, including the first 10 in the Bill of Rights, vary widely. The changes made to the original 1787 draft include the direct election of U.S. senators; limiting a president to two terms; the establishment of the federal income tax; allowing women and African Americans to vote; and the abolition of slavery. The only amendment to be repealed was the Eighteenth, which barred the sale and consumption of alcohol in 1919. Alcohol was made legal in 1933 with the creation of the Twenty-First Amendment.

Question #8: What did the Declaration of Independence do?

Action Sports Photography // Shutterstock

Answer #8: Announced independence (from Great Britain); declared independence (from Great Britain); said that the United States is free (from Great Britain).

The Declaration of Independence, written on July 4, 1776, was the first document that declared 13 colonies in America would become sovereign and separate from the Kingdom of Great Britain. Members of the Continental Congress, including Thomas Jefferson, Benjamin Franklin, John Adams, Roger Livingston, and Roger Sherman, created the document together. The Declaration of Independence is the first of three founding documents of the United States government, including the U.S. Constitution and the Bill of Rights.

Question #9: What are two rights in the Declaration of Independence?

Bev Sykes // Wikimedia Commons

Answer #9: Life; liberty; pursuit of happiness.

The first two rights of the Declaration of Independence guarantee the rights of citizens to exist frequently. The third right, the pursuit of happiness, is commonly understood to refer to the right to one's own wealth and property.

Question #10: What is freedom of religion?

ildintorlak // Shutterstock

Answer #10: You can practice any religion, or not practice a religion.

The freedom of religion is also known as the separation of church and state. This amendment prohibits the government from making citizens practice a particular set of moral beliefs. There are two accurately named sections in the First Amendment that concern religion. The Establishment Clause forbids the government from setting up a system of faith or favoring one religion, and the Free Exercise Clause prohibits the government from barring the exercise of faith or lack thereof.

Question #11: What is the economic system in the United States?

You may also like: Defining historical moments from the year you were born

javen // Shutterstock

Answer #11: Capitalist economy; market economy.

Capitalist and market economies make up the U.S. financial system. A capitalist economy consists of private owners and corporations manufacturing goods with minimal government involvement. A market economy is the supply and demand system operated by individual owners and corporations, who produce and price products, and compete to be leaders in their respective industries.

Question #12: What is the "rule of law"?

sergign // Shutterstock

Answer #12: Everyone must follow the law; Leaders must obey the law; Government must obey the law; No one is above the law.

No man, woman, or child, regardless of his or her economic, education, or societal status, is removed from the regulations set forth by the three branches of government. Even the president, who is commander-in-chief of the U.S. Armed Forces, must follow specific laws to remain the leader of the country.

Question #13: Name one branch or part of the government.

Alex Wong // Getty Images

Answer #13: Congress; legislative; president; executive; the courts; judicial.

One branch of the government is the U.S. Congress, which is made up of two chambers including the Senate and the House of Representatives. The Senate is considered the more powerful committee, which is made up of fewer members who collectively hold different rights from those of the House, including the sole authority to conduct an impeachment trial or to reject a presidential appointee to either the executive or judicial branch.

Question #14: What stops one branch of government from becoming too powerful?

Michal Kalasek // SHutterstock

Answer #14: Checks and balances; separation of powers.

There must be a check and balance system between the three brancheslegislative, executive, and judicialof government to assure each entity only exercises its specific responsibilities. Each branch has the capacity to affect the decisions of other branches in specific ways. This separation of powers prevents any one branch of government from dominating its counterparts, keeping the federal system fair and equal.

Question #15: Who is in charge of the executive branch?

Ad Meskens // Wikimedia Commons

Answer #15: The president.

The executive branch is made up of the president, vice president, and Cabinet, and the president is in charge as the head of government and the commander-in-chief of the armed forces. The Twenty-Second Amendment forbids any person elected to the office of the president from serving more than two consecutive four-year terms. There have been 13 presidents who have served two terms, including Grover Cleveland, who served in nonconsecutive periods.

Question #16: Who makes federal laws?

You may also like: Oldest national parks in America

Jesse Collins // Wikimedia Commons

Answer #16: Congress; Senate and House (of Representatives); (U.S. or national) legislature.

Federal laws are created when the U.S. Congress passes legislation, the president signs an executive order, and/or a federal court decision is reached based on the U.S. Constitution. When the U.S. Congress creates and passes bills, the proposed legislation must be approved and signed by the president to become federal law.

Question #17: What are the two parts of the U.S. Congress?

Katherine Welles // Shutterstock

Answer #17: Senate and House (of Representatives).

The two chambers of the U.S. Congress include the Senate and the House of Representatives. The upper chamber is the Senate, which is made up of two senators from each of the 50 states. The lower chamber is the House of Representatives, which is made up of a variable number of representatives from each state and the District of Columbia based on that state's population. Since 1911, there have been 435 representatives in the House at any given time.

Question #18: How many U.S. Senators are there?

Public Domain // Wikimedia Commons

Original post:
Could you pass the U.S. citizenship test?: There are 100 questions on the civics section of the U.S. citizenship test. Applicants are asked ten of...

Posted in Second Amendment | Comments Off on Could you pass the U.S. citizenship test?: There are 100 questions on the civics section of the U.S. citizenship test. Applicants are asked ten of…

Group files federal lawsuit against City of Highland Park for ‘assault weapon,’ high-capacity magazine ban – Lake and McHenry County Scanner

Posted: at 10:13 pm

M4A1 Carbine | Photo: IIIBlackhartIII via Pixabay

A gun-rights advocacy group filed a lawsuit in federal court against the City of Highland Park on Wednesday, alleging their assault weapons and high-capacity magazine bans are a violation of the Constitution.

The National Association for Gun Rights (NAGR) filed the lawsuit in the U.S. District Court for the Northern District of Illinois.

Plaintiff and Highland Park resident Susan Goldman owns semi-automatic firearms and magazines that can hold more than 10 rounds, according to the lawsuit.

Goldman stores her firearms outside of the city limits, in accordance with a 2013 ordinance banning assault weapons and high-capacity magazines.

She [Goldman] is especially aggrieved by the fact that the Citys prohibitions require her to store her arms outside the city limits, which requirement renders the arms useless for the defense of her home, the civil complaint said.

NAGR refused to use the term assault weapon in their lawsuit, calling it a rhetorically charged political term.

The group challenged the citys ban, citing the Second Amendment and the U.S. supreme court cases of District of Columbia v. Heller, McDonald v. City of Chicago and New York State Rifle & Pistol Association, Inc. v. Bruen.

NAGR asked the court to declare sections of the ordinance unconstitutional on their face or as applied to the extent their prohibitions apply to law-abiding adults seeking to acquire, use, transfer, or possess arms that are in common use by the American public for lawful purpose.

A victory here will establish good legal precedent throughout the entire circuit, including Wisconsin and Indiana, the group said in a statement.

NAGR also filed four other lawsuits against states or cities across the country, including Naperville.

States have been ignoring the Second Amendment and the HellerandMcDonalddecisions for far too long and law-abiding gun owners are sick and tired of their unconstitutional antics, which disarm millions of Americans, President of the National Association for Gun Rights Dudley Brown said.

In light of the Bruendecision and the success weve had in suing localities in Colorado, were going after every Federal Circuit Court which has upheld egregious firearms bans. They must immediately overturn their assault weapons and magazine bans and our suits argue just that, Brown said.

The Highland Park City Council passed a resolution in August supporting statewide and federal bans on assault weapons and high-capacity magazines.

The resolution called them a threat to our American freedom.

It came after a mass shooting in the city during a Fourth of July parade left seven people dead and over 45 injured.

Robert Crimo III, 21, of Highwood, was charged with 21 counts of first-degree murder, 48 counts of attempted murder and 48 counts of aggravated battery with a firearm.

Crimo allegedly fired a total of 83 rounds using three 30-round magazines from his Smith & Wesson M&P 15 semi-automatic rifle, Lake County Assistant States Attorney Ben Dillon said during a bond hearing in July.

The Lake County Board passed a similar resolution supporting state and federal legislation to ban the sale and possession of assault rifles.

NAGR asked the courts to strike down the gun control laws, hoping to establish a nationwide precedent.

We are simply asking for the courts to enforce the Supreme Courts pro-gun Bruen ruling by re-evaluating and striking down each of these gun control laws under the new national standard which outlaws gun controls that are not consistent with the text, history, tradition of the Second Amendment as required in the Bruen decision, Brown said.

Original post:
Group files federal lawsuit against City of Highland Park for 'assault weapon,' high-capacity magazine ban - Lake and McHenry County Scanner

Posted in Second Amendment | Comments Off on Group files federal lawsuit against City of Highland Park for ‘assault weapon,’ high-capacity magazine ban – Lake and McHenry County Scanner

How U.S. Businesses Can Help Reduce Gun Violence in Their Communities – HBR.org Daily

Posted: at 10:13 pm

Northwell Health, New York states largest health care provider, has been a leader among organizations trying to reduce gun-related violence in the United States. In 2020, it created a center thats dedicated to that effort. In this article, its CEO and the head of the center offer five steps that leaders of all organizations can take to help address this public health crisis.

As leaders at Northwell Health, New York states largest health care provider, weve seen mass shootings and other random acts of gun violence become deadlier and more frequent. In 2021, the United States experienced more firearm-related deaths than any year on record 48,832 to be exact, according to provisional data published by the Centers for Disease Control and Prevention (CDC). Firearms are now the leading cause of death among children and adolescents. Across our own health system, weve already seen more firearm injured patients this year than any other in our history. While our nation struggles to find solutions to this epidemic, hospitals, health systems, businesses, and all other types of organizations have a responsibility to take an active role in reducing gun violence in America.

The gun safety legislation approved by Congress and signed into law by President Biden in June (known as the Bipartisan Safer Communities Act) was certainly a welcome first step. But theres still much work that must be done to reverse the continuing spike of firearm injuries whether it be firearm-related homicides and violence, suicides, unintentional injuries, or mass shootings that are plaguing communities.

The only way thats going to happen is if members of the business community and other sectors recognize gun violence as the public health crisis that it is. Here are five steps that leaders of organizations can take right now to help prevent gun violence for the sake of their communities, consumers, and employees:

This is an approach embraced by Northwell and a growing number of other health systems and corporations nationwide. In 2020, we created a Center for Gun Violence Prevention to use data-driven strategies to chart a public health approach to gun violence prevention and lead our efforts across health care and community settings to address the underlying causes of gun violence in the New York area and beyond. One of us (Chethan Sathya) was appointed to head it because of his experience as a pediatric trauma surgeon who has treated many children with gunshot wounds and his passion for pursuing prevention efforts.

Creating a dedicated unit headed by a committed frontline champion and supported by a passionate C-Suite leader one who is ideally already engaged with local community and business leaders demonstrates an organizational commitment to address this public health crisis. It empowers employees to have open dialogue and share experiences, lead prevention efforts in their own communities, and become agents of change throughout their own institution. This works wonders in inspiring people to find common ground and support practical solutions, rather than engaging in Second Amendment debates mired in politics.

Depending on your organizations employee makeup and a community assessment of the type of gun violence most prevalent in your area, it may make sense to focus on one type of firearm injury such as firearm homicide and violence, suicide, or unintentional injury or a particular age group.

One candidate to consider is gun violence affecting children and adolescents, which has surpassed motor vehicle crashes as the leading cause of death for children in America. According to the most recent finalized data, all firearm-related deaths in the United States totaled 45,222 in 2020, a 13.9% increase from 2019, while those of children and adolescents (persons up to 19 years of age) skyrocketed by 29.5%. This public health crisis is having an especially devastating effect on Black children and adolescents.

In addition to being less polarizing politically, focusing on gun violence affecting young people gives organizations the opportunity to find common ground with parents from all communities and interact with young people in ways that can make a real difference.

Investments in community violence intervention and programs that address inequity and social determinants of health such as employment and food insecurity can have a big impact. These initiatives can help break the cycle of violence by helping young people get on a better path where they can avoid becoming victims or instigators of gun violence.

Another initiative that can make a major difference is one aimed at getting more gun owners to store their weapons safely, significantly reducing the risk of firearm injury among children and family members in the household. Its estimated that 4.6 million children in the United States live in homes with at least one loaded and unlocked gun. Eight American children are killed or injured every single day with an unsecured firearm. And 80% of the guns used in mass shootings committed by children under the age of 18 are unsecured weapons owned by parents, relatives, or friends. Numerous studies conducted over several decades have shown that access to unsecured firearms in the household substantially increases the risk of firearm injury and death.

Employee education can be a powerful means to reduce gun violence among your own employees and the community at large. In our health system, we not only educate our employees about gun safety; we also screen our patients who may be at risk of gun violence in the communities where they live and work and provide preventative resources when needed.

With the help of a $1.4 million grant from the National Institutes of Health, clinical team members at three Northwell hospitals are screening and counseling all patients who have access to firearms on safe storage practices, providing them with gun locks, and connecting those living in communities with high risk of firearm violence to community services aimed at keeping them safe and out of trouble. You can do the same with your employees.

We also encourage you to include a training module on gun safety and firearm-violence prevention during the onboarding process or and in other training programs. Given that there are 400 million guns in America, the more education we do about safe firearm storage, responsible gun ownership, and ways to prevent firearm violence the better.

Work closely with your human resources leaders to develop materials for employees and a corporate strategy to respond after gun violence occurs locally. They include information on the following:

If your organization has the resources, support local groups that are trying to reduce gun violence. If your organization is in a city, chances are there are community violence intervention (CVI) programs. They work directly with people who are at risk of committing gun violence or becoming victims of it. Such personalized, high-touch support and interaction can interrupt cycles of conflict that drive a significant portion of gun violence. CVIs also serve as a bridge between hospitals and the communities which is important since hospitals can screen patients to identify those at risk of suffering firearms-related injuries and can provide preventative resources.

If you want to also focus on promoting firearm safety and safe storage practices, there are many groups you can work with. They include law enforcement, health care, mental health organizations, responsible gun owners, advocacy groups, schools, and government all of whom often have diverse initiatives focused on firearm safety in the community.

Just as leaders of private and public sector organizations helped mitigate the impact of Covid-19, you can help support public health campaigns to reduce gun violence. You can talk about this issue with your employees and peers, in public appearances, and on social media. You can advocate for policy changes rooted in public health principles like safe storage and violence intervention, and you can support the need for more research funding. Without better data and better research, we will never be able to make meaningful progress on curbing this epidemic. And by taking a public stance, you can help reframe gun violence as an apolitical public health issue.

We strongly believe that the most effective public health solutions to gun violence must come from the federal government in the form of universal background checks, a ban on weapons of war, safe-storage requirements, research funding, and investments in trauma-informed care and mental health. That said, every private and public sector organization has a part to play in curbing this epidemic.

If leaders of corporations and other large organizations decide that the needless bloodshed ravaging the United States every day is unacceptable, they can help turn the tide. As health care leaders, every ounce of our effort goes into saving lives and helping people live healthy and safely. We want and need broad-based support. Please join us.

Originally posted here:
How U.S. Businesses Can Help Reduce Gun Violence in Their Communities - HBR.org Daily

Posted in Second Amendment | Comments Off on How U.S. Businesses Can Help Reduce Gun Violence in Their Communities – HBR.org Daily

LETTER: We need Bailey to restore Illinois | Letters | pantagraph.com – The Pantagraph

Posted: at 10:13 pm

I would like to write and tell you the reasons we need a good governor, like Darren Bailey, in office to help restore Illinois.

Darren Bailey has fought for the community, the kids and the parents.

Reopening the economy and schools: As governor, he will work to fully reopen the economy and our schools, attract new business, and fuel job creation in Illinois.

Pro-life: As a man of faith, Darren is proudly pro-life and will always stand up to protect the rights of the unborn. As governor, he will continue to defend innocent life.

Second Amendment: Darren is a strong supporter of the Second Amendment and an advocate for the constitutional right to bear arms. As governor, he will continue to protect the Second Amendment.

Education: Darren, along with his wife, founded a preschool through grade 12 Christian school in southern Illinois and he understands the importance of access to quality education. As governor, he will advocate for common sense education reforms that put our children first.

Taxes: Darren firmly believes in fiscal responsibility and knows that every penny matters. Raising taxes hurts hardworking Illinois families and is not a solution for a state with some of the highest tax burdens in the entire nation. As governor, he will work to lower both property and income taxes.

Agriculture: Darren is a third-generation farmer who owns and operates his own family farm today. He knows that agriculture is the backbone of Illinois economy. As governor, he will stand up for his fellow, hardworking farmers.

Government transparency: Darren Bailey fights for the working people, not the political elites. As a legislator, he refuses state pension benefits. As governor, he will promote transparency and ensure safeguards against powerful government overreach.

To restore Illinois, we need Bailey in office.

DawnBergeron,Bloomington

Get opinion pieces, letters and editorials sent directly to your inbox weekly!

More:
LETTER: We need Bailey to restore Illinois | Letters | pantagraph.com - The Pantagraph

Posted in Second Amendment | Comments Off on LETTER: We need Bailey to restore Illinois | Letters | pantagraph.com – The Pantagraph

Providing a sense of calm The Licking News – The Licking News

Posted: at 10:13 pm

Photo by Christy PorterLPD Chaplain Paul Richardson (left) participates in training with the department to ensure his safety, the safety of the officers (Officer Kaleb Berkshire, center, and Summersville Police Chief A.J. Reef, right, shown here), and the safety of the public when he is assisting law enforcement on calls.

By Christy Porter, Managing Editor

Licking Assembly of God Senior Pastor Paul Richardson is an integral part of the Licking Police Department as volunteer chaplain. Richardson took the more formal volunteer position after the departure of Darius Wentz, already having an established relationship with the LPD. Pastors in the Licking community consistently work with the police department providing faith-based Christian assistance when necessary, such as with the Ministerial Alliance.

Richardson has completed additional training and certification to join the police department in this capacity. As a small town boy, he grew up being comfortable with guns, hunting and participating in competitive pistol shooting. Being a part of the LPD training makes him more comfortable with the different scenarios that may take place when joining law enforcement on duty. However he emphasizes that every citizen who practices their second amendment rights should get training; it is a big responsibility.

Chaplains do not make arrests, give tickets or execute other police duties. But like any concerned citizen, a chaplain will not hesitate to jump into a situation if an officer or someone is in danger, clarified Richardson.

Primarily, chaplains provide a sense of calm in the midst of challenging situations. Thats why hospitals, hospices, the military, and even the prisons utilize chaplains. In law enforcement, chaplains provide a sense of calm through presence, conversation, counseling, and other pastoral and spiritual practices, said Richardson. Chaplains can be called upon to assist in death notifications, calm families during a tragedy or provide support during domestic situations.

Another aspect of the chaplaincy is being available to the officers when they need to talk. I ride with them on some of their shifts, providing conversation during uneventful shifts and a second set of eyes or hands during more eventful shifts.

This experience makes Richardson more aware of the levels and complexity of law enforcements job. He is always available, and often present for the raw moments, acting as counselor, therapist and mediator, and monitoring the situations as they unfold, working as a part of the team. Seeing places in the community that were, literally, previously unknown to him, even after 12 years in the community, has been somewhat of a surprise.

Mostly, chaplaincy is a ministry of presence: Just being there can be helpful to families, communities, or officers during the midst of tragedy, summarizes Chaplain Richardson.

More:
Providing a sense of calm The Licking News - The Licking News

Posted in Second Amendment | Comments Off on Providing a sense of calm The Licking News – The Licking News

Consultation held on amendment to child rights act – The News International

Posted: at 10:13 pm

Islamabad : A consultative meeting was convened by the National Commission on the Rights of Child (NCRC) to discuss the proposed amendments in the NCRC act, 2017 to make the Commission a fully independent National Human Rights Institution (NHRI) as enshrined in the Paris Principles.

The meeting was presided over by Jawad Ullah, the Acting Chairperson from NCRC. Those who attended the meeting included Chief of Child Protection UNICEF Daniela Luciani, Child Protection Specialist UNICEF Farah Ilyas, legal experts and representatives from civil society including Child Rights Movement (CRM) and NACG Pakistan.

Acting Chairman Jawad ullah shared the objectives of the consultation where the amendments are being proposed in NCRC Act, 2017 to cure the shortcomings of the original statute ensure adequate representation of all provinces in its constitution and empower it for advancing the cause for which the NCRC is established.

Atta Ul Mustafa, Legal Advisor, explained the theory and practice of National Human Rights Institutions (NHRI) in Pakistan. He explained how the presence of well defined mandate is integral for the effective functioning of National Human Rights Institutions (NHRI).

Furthermore, Chief of Child Protection section UNICEF of Pakistan, Daniela Luciani acknowledged and appreciated the efforts of National Commission on Rights of Child for the protection, promotion and advancement of child rights. She further stressed that presence of a coherent legislation, governing the mandate of NCRC, is imperative for the effective functioning of the commission.

Legal experts Tayyab Ali Awan and Laiba Qayyum, proposed the NCRC (Second Amendment) Bill 2022 for discussion before the relevant stakeholders from civil society. The rationale behind the proposed amendments was to strengthen the mandate of the commission, stipulate a coherent process of appointment and removal of members, and allocate a seat for Gilgit-Baltistan in the commission to ensure its adequate representation. Additionally, the extension of suo-moto powers to the commission were also discussed to effectively curtail the violation of child rights.

Dr Rubina Fareed (Member ICT) concluded the meeting and thanked the participants for their contributions. She further stated that before finalization of the Amendment Bill she will take government stakeholders on board and incorporate recommendations The Federal Government has constituted the National Commission on the Rights of Child in exercise of powers conferred by Section 3(1) of the National Commission on the Rights of Child Act, 2017 (XXXII of 2017) under a notification issued on February 28, 2020. The Commission has an overarching mandate in accordance with international obligations under the United Nations Convention on the Rights of Child (UNCRC) and for matters related to the promotion, protection and fulfilment of child rights as enshrined in the NCRC Act 2017.

Read the original:
Consultation held on amendment to child rights act - The News International

Posted in Second Amendment | Comments Off on Consultation held on amendment to child rights act – The News International

Daily Skimm: Psychedelics, The DOJ, and iMessages – theSkimm

Posted: at 10:12 pm

The Story

A psychedelic could treat depression.

Yesterday, a newly-published study found that ketamine was effective at reducing symptoms of suicidal thoughts, depression, and anxiety. During a year-long period involving over 400 patients, about three-quarters saw their moods improve. And nearly 40% say they were symptom-free after 10 infusions of ketamine.

Thats because ketamine (aka Special K) is used by some to get a psychedelic high. But its also used medically and legally as an FDA-approved anesthetic. And it's increasingly used as an off-label mental health treatment. ketamine is also proven effective in treating psychiatric conditions like eating disorders. Now, the real-world data from the study is giving experts a better understanding of the drug. And it couldnt come at a better time

Last month, the new 988 Suicide and Crisis Lifeline saw a 45% uptick in calls, chats, and text messages compared to the year before. And it comes as Americans have seen reported increases in rates of anxiety and depression since the pandemic began. If youre struggling with symptoms of depression, youre not alone.

While ketamine could prove to be a game changer for mental health, researchers say more trials are needed to assess the drug's full effects. But reminder: psychedelics are still illegal in most of the US.

PS: If you or someone you know is struggling with suicidal thoughts, call the National Suicide Prevention Lifeline at 988.

The Justice Dept. Since last week, the DOJ has reportedly subpoenaed around 40 of former President Trump's associates. Its considered a significant escalation in the DOJs investigation into the Jan 6 Capitol riot and other attempts to overturn the 2020 election. The subpoenas were sent to everyone from low-level aides to senior advisers. The DOJ also seized two cell phones that were apparently in connection with the fake elector plan. Aka the alleged plot to overturn the 2020 election by submitting fake electors in seven swing states like Georgia, Pennsylvania, and Arizona...the ones President Biden won by thiiiis much. It comes as the Jan 6 House committee is nearing the end of its investigation. They could decide whether to request testimony from Trump and former VP Mike Pence as early as today.

...Oh and in other Trump news, the DOJ's signaling it's open to one of Trump's picks for a special master. Judge Raymond Dearie could serve as the third party person to review the docs taken from Mar-a-Lago last month. But a federal judge overseeing the case needs to sign off.

Nurses. Yesterday, about 15,000 nurses in Minnesota walked out on their jobs across several hospitals to protest understaffing and work conditions. Its reportedly the largest protest in US history involving private sector nurses. They claim some units operate without a lead nurse on duty. And that inexperienced nurses are saddled with tasks more senior figures usually handle. Now, the protest is expected to last three days. The nurses are asking to have a say in staffing plans and pay bumps over 30%. And the president of the Minnesota Nurses Association says meeting their wage demands will help resolve retention problems. But hospitals say they cant afford the wage demands and say the nurses have refused to meet at the mediating table.

Johnson & Johnson. Over the weekend, the company reached a settlement in Australia over allegedly selling defective pelvic mesh. The material is often used in women who are suffering from urinary incontinence (which can be common after childbirth and menopause) or to help hold pelvic organs in place. J&Js been in trouble for this mesh before. Earlier this year, a California court ordered them to pay $302 million for not being upfront about the risks. But thousands of women filed complaints against J&J, alleging the companys pelvic mesh led to chronic pain, urinary problems, and painful sex. Now, Johnson & Johnson will be paying $300 million in two class action suits.

The Emmy Awards.

iMessage is letting people hit the edit button.

Link:

Daily Skimm: Psychedelics, The DOJ, and iMessages - theSkimm

Posted in Psychedelics | Comments Off on Daily Skimm: Psychedelics, The DOJ, and iMessages – theSkimm

Inside the UK’s new psychedelic drug trial clinic trying to treat depression and anxiety – iNews

Posted: at 10:12 pm

Ali has suffered from depression since she was 12 years old. Now a trained paediatric nurse living in Bristol, she has taken antidepressants and other medication for most of her adult life. In her late twenties, following the death of a close friend, Alis depression spiralled and she was unable to continue working. Trapped at home, the drugs she was being prescribed were causing her to gain weight, have recurring nightmares and sleep paralysis.

I was in a desperate place, Ali recalls. I had tried all sorts of therapies and medications. I was on really high doses. I think my mental health team didnt know what else to do with me. In 2019, Ali joined a trial being run by David Nutt, professor of neuropsychopharmacology at Imperial College, and Robin Carhart-Harris, head of Imperials Centre for Psychedelic Research, testing the impact of psilocybin the main active ingredient in magic mushrooms alongside psychotherapy, in 59 people with moderate to severe depression.

During her first psilocybin trip Ali experienced euphoria and a kind of spaciousness that was very different from the insular, crushing feelings of depression. She recalls wandering outside her own body through a cathedral-like building. In her second dosing session she travelled through different landscapes and memories. During one stage she was reunited with her deceased friend. I floated as a river with her for what felt like hours. It was a way of saying goodbye because I didnt get to do that, she recalls.

Not only were these psychedelic experiences life-affirming for Ali, but they also liberated her from myopic ways of thinking: I felt like myself for the first time in a long time. I wasnt completely free from my depression, but I was able to start seeing the good in life again and enjoy things, she explains. I promised myself that I was going to try to live, and to enjoy life.

During the trial, Prof Nutt and his colleagues found the psilocybin, when used in conjunction with therapy, produced rapid antidepressant effects. It was as effective as escitalopram (used to treat depression) and scored better in two key areas: participants reported a better sense of wellbeing and 58 per cent were considered in remission six weeks after treatment, compared with 28 per cent in the escitalopram group.

Prof Nutt has been researching psilocybin for around 20 years, but interest in psychedelic treatments is growing. Research from Kings College, London, published in January 2022, evaluated the safety of psilocybin as part of therapy in the largest randomised controlled trial of psilocybin in the UK to date; documentaries like Michael Pollans How to Change Your Mind are reaching new audiences on Netflix; and this month Europes first commercial facility for psychedelic drug trials is opening in central London.

Situated in an Edwardian townhouse off Harley Street, the clinic is a bland place with revolutionary aims. Apart from its calming dcor and opaque curtains there are few indications that it is a site where participants will experience mind-bending drug trips. But while the new era of psychedelic research might have its roots in the hippie communes of the 60s, and the turn on, tune in, drop out mantras of US psychologist Timothy Leary and his LSD acolytes, todays practitioners are rigorous, data-driven scientists.

Later this month, a team of around a dozen scientists, psychotherapists and clinicians will step into this newly renovated facility to launch Clerkenwell Health, a commercial contract research organisation (CRO) founded to facilitate clinical trials to test psychedelics for drug developers.

If you listen to the psychedelic purists of the 60s, the only setting is a hut in the middle of the Amazonian jungle, but thats been a challenge to reproduce in Central London, Emilio Arbe, Clerkenwells chief medical officer, tells i.

Since the ultimate aim is to bring these treatments to mainstream psychiatry, weve moved away from anything too exotic.

The first trials here, scheduled to begin in October, will test the effects of psilocybin, along with psychotherapy, on around 60 cancer patients struggling with terminal diagnoses. After three sessions of psychotherapy, half will receive the drug and half a placebo. The trial is being conducted for the Toronto-based biotech company, Psyence.

Using these drugs for psychiatric therapy isnt new. English psychiatrist Humphrey Osmond famous for trying to cure alcoholism with LSD coined the term psychedelic in 1956 in a letter to writer and mescaline user Aldous Huxley. The same year British psychiatrist Ronald Sandison was working in the worlds first purpose-built LSD unit at Powick psychiatric hospital near Malvern in Worcestershire, using the substance to help treat depression and schizophrenia.

In the late 60s and early 70s countries including the US and UK moved to make the use of LSD and psilocybin illegal. In the UK, the Misuse of Drugs Act (1973) also restricted medicinal use. Both remain Class A, schedule 1 listed drugs, meaning they are illegal and officially classified as having no medical use. The ruling has severely restricted, but not prohibited, clinical research into the ways psychedelics can influence the mind.

Clerkenwell is not the first organisation in the UK to experiment with mind-altering substances, but it is the first commercially funded venture to conduct clinical trials on its premises.

Having a specialist facility for psychedelic drug trials is essential to help bring new treatments to market, says co-founder and chief scientific officer Henry Fisher. A drug development company wants to run a clinical trial as quickly, efficiently, and safely as possible, he says. Its not just about giving someone a drug. The therapy is a vital and fundamental component to the intervention, as is the setting in which its delivered.

Like Ali, Ian Roullier, 45, has also taken psilocybin as part of a previous clinical pilot run by Imperial College London in 2015. After suffering for years from anxiety and depression, Roullier hit rock bottom in 2014. As a journalist he had worked himself to the point of exhaustion and was feeling burnt out. He took various types of antidepressants to try to find some respite from his low moods but they only made him feel numb and lifeless. After hearing about the trial at Imperial he enlisted, desperate to see if psilocybin-assisted therapy could help.

Roullier describes the ordeal as a visceral and challenging exercise. During his hallucinatory trip he engaged with feelings and emotions he had been avoiding for years. It was a Wizard of Oz moment, Roullier recalls. That doesnt mean that everything was rosy and beautiful, but my anxiety and depression had lifted. I approached situations openly, the self doubt, and self recrimination in my head had faded away.

Psilocybins potential to be a therapeutic enabler seems to stem from its ability to break down the rigidity of depressive thinking. Brain scans show that it increases connectedness between different parts of the brain. In particular, the compound stimulates a serotonin receptor in the cortex linked to neuroplasticity. Nutt hopes that it can induce fresh states of consciousness and not only unearth repressed memories, but when aligned with therapy help people re-evaluate them, and thus think differently about their future.

The first major insight we found was that psilocybin dampens down a part of the brain that is one of the driver hubs for depression, Nutt explains. We knew that antidepressants and psychotherapy did that, but usually it takes weeks or months to happen. With psilocybin, it happened within minutes.

The other conclusion Nutt and his colleagues drew was that psilocybin disrupted a part of the brain that contains our sense of self, a faculty that commandeers more brain activity in depressed people.

Sarah Bateup, therapy lead at the Clerkenwell clinic, believes that psychedelics like psilocybin could yield significant breakthroughs in mental healthcare. If youve had depression for 20 years, youve had therapy 10 times, youve tried every drug, youve had electroconvulsive therapy, and you dont get better, youre already thinking: Im not curable.

A psychedelic like psilocybin creates this window of opportunity, where the person is very open and more receptive to therapy, she adds. But she stresses that psychedelic-assisted therapy is a novel and highly challenging form of psychiatric care, and one that carries significant risks. After all, these substances are powerful and unpredictable.

Were being very robust, scientific and evidence based, Bateup says. We also think that its very important to strip out the symbolism that comes with psychedelics. If this is a medicine of the future, then it needs to be fit for world health systems its our responsibility to do high quality research, and show people that were boring scientists and clinicians, not people that have done too many drugs.

There is a growing interest in using other drugs, such as MDMA and ketamine in mental health treatments. Awakn, a life sciences firm with clinics in Bristol and London, is researching the potential for ketamine and MDMA to treat alcoholism, gambling addiction, binge eating, and sex addiction. In the US, treatments that include MDMA are likely to be approved soon for patients with post-traumatic stress disorder (PTSD), though regulator approval in the UK is likely to take longer.

Meanwhile, Compass Pathways, a mental health care company and developer of a synthesised psilocybin, has this year announced a collaboration with Kings College Hospital and South London and Maudsley NHS trust to accelerate research into emerging psychedelic therapies.

To ensure that Clerkenwell delivers safe and beneficial treatments, Bateup has devised a training programme to help therapists work across multiple conditions with a range of psychedelic compounds. The screening process has been extremely rigorous.

We dont just take people that have the right qualifications, Bateup says. Were looking for scientists and practitioners who can reflect on their work, take feedback, and always want to be learning.

It is this thorough approach that Roullier has also sought to champion. In 2021 he set up The Psychedelic Participant Advocacy Network (PsyPAN) with Leonie Schneider, another participant in the second Imperial trial. The non-profit aims to connect a global network of participants in psychedelic trials. By pooling together these lived experiences, they hope to help clinicians create more effective treatment models, and improve participant safety and wellbeing.

Although trials do indicate some successes, they are still limited and operating on a small-scale number of patients. These treatments may be very effective tools but its very important to push back a bit, Roullier advises. Weve gone from these drugs drive you mad to these drugs could cure this condition for ever. Even when psychedelics do work, Roullier stresses that they are not a quick fix. Roullier still suffers with depression, but he has not taken antidepressants since taking part in a second psilocybin trial in 2019, and regularly attends counselling sessions.

Im living proof that one trial doesnt fix you for ever. Psychedelics have huge potential, but it would be simplistic to say that they are the answer to the mental health crisis, Roullier cautions. We need to deliver these treatments as ethically and safely as possible, so they have the best chance of making it to market.

For Bateup, while psychedelic-assisted therapy is a challenging and nascent field, the biggest gamble would be to keep things as they are. Our mental health care system is pitiful and its getting worse. Treatment outcomes have stagnated. Nobodys invented anything new, she says. Theres a big group of people who are really suffering, and this could be something that makes a huge difference to them. Thats what I want. Thats what its all about.

Original post:

Inside the UK's new psychedelic drug trial clinic trying to treat depression and anxiety - iNews

Posted in Psychedelics | Comments Off on Inside the UK’s new psychedelic drug trial clinic trying to treat depression and anxiety – iNews

What A Trip: Delix Therapeutics is Treating Mental Health at Scale with Psychoplastogens – Genetic Engineering & Biotechnology News

Posted: at 10:12 pm

Mark Rus, MSc., Chief Executive Officer and Director of Delix Therapeutics.

Clinical interest in psychedelic chemicalsclassic hallucinogens like LSD (D-lysergic acid diethylamide) and dissociative drugs like ketamineis becoming increasingly mainstream. In 2019, the U.S. Food and Drug Administration (FDA) approved a nasal spray called esketamine (Spravato) containing a ketamine-like compound for treatment-resistant depression.

Although ketamine and now esketamine are available in clinics, most psychedelic compounds remain illegal. Psilocybin, the magic ingredient in psychedelic mushrooms, is farthest down the path to FDA approval. Just a few weeks ago, researchers at NYU Grossman School of Medicine showed that two doses of psilocybin, a compound found in psychedelic mushrooms, reduce heavy drinking by 83 percent on average among heavy drinkers when combined with psychotherapy.

Besides the issue of legality, taking psychedelic compounds has risks. In addition to poisoning, there are long-term side effects that include memory loss, seizures, and anxiety. Also, the eponymous side effects of psychedelic compoundshallucinations (seeing the world turn into fractals, hearing voices, or tasting colors) and dissolution (feeling out of control or disconnected from their body and environment)pose a risk to serious harm because of the profound alteration of perception and mood. While not inherently dangerous, consumption of psychedelics has led people to harm themselves and others while having a mind-altering experience, with tales of people becoming suicidal and violent.

To harness the clinical power of psychedelics, the mechanism of action underlying the antidepressant and anxiolytic effects need to be separated from hallucinatory and dissolutive. Research has shown that result from their ability to promote structural and functional plasticity in prefrontal cortical neurons. Isolating the chemical structures driving the rapid and long-lasting antidepressant and anxiolytic effects of psychedelics may be used as lead structures to identify next-generation neurotherapeutics with improved efficacy and safety profiles.

Delix Therapeutics is a neuroscience company focused on harnessing the power of isolating psychoplastogensnovel neuroplasticity-promoting therapeuticsto better treat mental health disorders at scale. Based in Boston, Massachusetts, the companys compounds, which do cause not cause hallucinatory or dissociative side effects, are easily manufactured small molecules capable of rapidly inducing structural and functional neural changes in targeted brain areas. Many of these molecules are inspired by psychedelic compounds and preserve their efficacy-promoting mechanisms while avoiding their hallucinogenic properties and other safety liabilities.

GEN Edge has taken a look into the motivation and structure of Delixs R&D pipeline with CEO Mark Rus, a veteran industry executive. He joined Atlas Venture after previously leading Shire Pharmaceuticals Global Neuroscience Business.

GEN Edge: What motivated the founding of Delix Therapeutics?

Rus: Neuropsychiatry and neurodegeneration have had a shortage of innovation for the past few decades. Were still using a similar selective serotonin reuptake inhibitor (SSRI). You cant even find meaningful advances on the neurodegenerative side. Pick your access moral, strategic, or financial. All roads lead to the need for better mental health treatments. The treatments do not match the unmet need in the space.

Through that motivation, Delix co-founder David Olson was working on ketamine at the Broad Institute on why these rapid structural and functional changes, called neuroplasticity, occur in the PFC. We know the intangible benefits associated with like ketamine or true psychedelics like psilocybin. Perceived dissolution of ego and the unique intrinsic experiences that one can have are very powerful. Who am I to say that those cant be the most transformative experiences for someone in their lives?

But Im a neuro drug developer, and Im more interested to know whats happening at the synapse or circuit-based level. It was inconceivable to me that structural and functional neuroplasticity did not play a role. That ultimately led to the foundation of Delix.

GEN Edge: How do psychoplastogens work?

Rus: If you think of a neuron as a trees trunk, the dendrite is the branch coming off that tree and the synapses or the leaves on the edge of the branches. A well-functioning circuit connective circuit of pre-frontal cortex (PFC) to other brain parts is like a rich forest, where the neurons are all connected. But then, in a scenario where theres trauma, whether genetic or external, in both cases, those leaves start falling off, the dendrite branches retract, and the synaptic connectivity in the circuit is essentially lost or suboptimal.

To me, thats a fascinating nexus that sits at the heart of a range of neuropsychiatric and neurodegenerative conditions. So, why do psychedelics seem to help so quickly and so robustly? Its an indisputable fact that there is a massive and significant growth in the dendritic spine density process called synaptogenesis. David and I felt it was worth pursuing and drawing that lineup further. There are great companies, people, and funding behind hallucinatory-based approaches. But what if you could do it without the hallucinatory-based approach and some other aspects that may be suboptimal for some of these compoundsside effects, like HERG inhibition, other than removing the hallucinations?

For any brand, product, or therapeutic, I ask: What does it mean to a patient? Is it going to help? Will it make a difference in motivating them to want to take it? What does it mean for a payer and the prescriber? Is it sufficiently simple or motivating enough to change an ingrained habit that physicians may have in treating a particular condition? What does it mean for pharmacists, psychologists, and others in terms of ease of use? What does it mean for policymakers?

What motivated the Delix story was whether we could pursue the neuroplasticity-focused element, tease that out, and subtly tweak known hallucinatory compounds to generate our own novel IP. These eventually become very different compounds that, inspired by the hallucinatory ones, become more tolerable and orally bioavailable. You can take them home and thus be scalable to fit the current care frameworks and speak to the scalability of manufacturing, commercial, and patient access.

GEN Edge: What advantages do psychoplastogens have over hallucinogenic psychedelics?

Rus: I saw an inherent scalability issue regarding first- or second-generation hallucinatory psychedelics. Its not a reason not to do it. People can and will be helped by those experiences, but spending eight hours in an inpatient treatment clinic with multiple therapists surrounding you to support you and to walk you through that mission is one of the reasons why Spravatowhich a lot of people were excited by, the first ketamine derivative that was approved launched by Janssen and justifiably created a lot of motivation for our space and approved by the FDAhasnt been a huge success. Its tough to get high throughput payers to pay for it, and people that want to come back to take it with that high degree of complexity. Now, many people have been and will be helped with it.

There is a wide proportion of patients with comorbidities who will never even be candidates for hallucinatory psychedelic therapy. For someone with bipolar, schizophrenia, or a history of psychosis, its not the first, second, or third thing youd want to take to risk exacerbating that condition. When you start moving in that neurodegenerative direction and particularly individuals who are perhaps older or later in life, the ability to build rapport with therapists is plausible for some, and for others, it isnt. Im not sure how one discerns that early on.

So, the need for more options is there. Theres a mix of scalability, comorbidity, and other related reasons. That makes a lot of sense for more treatments in our approach. And thats what the Delix approach was all about. We wanted to take this non-hallucinatory approach to validate it preclinically. Ive been searching for the right scalable approach in this space because I see the promise that rapid structural and functional neuroplasticity changes may bring.

Delix is a psychoplastogen platform company. We now have thousands of compounds at this stage at various stages of characterization. We have two candidates that we nominated last year and moved into IND-enabling studies. We are in the process of completing those now. Well be in phase one early next year to show the translatability of this non-hallucinatory reality in man, efficacy, and safety with our approach while continuing to characterize, develop, and nominate subsequent candidates. We have a pipeline that we can produce from our platform as we drive forward the Structure-Activity Relationships (SAR) and the related screening discovery full of the scheme.

GEN Edge: What is the Delix R&D pipeline scheme?

Rus: Were certainly inspired by the fact that this work has been going on for a long time. Were standing on the shoulders of a lot of great work that has been going on for decades in the hallucinatory psychedelic space. But all our novel chemical and composition matter-supported compounds are synthesized and built in-house and are inspired by predicate compounds.

We have a phenotypic-driven drug discovery engine. Each one of these lens tests produces compounds that fit the Delix narrative for what an eventual clinical candidate would be. The first thing we do is assess for psychoplastogenic propertiesif something is a compound generating robust neurite outgrowth. We look at targeted binding and functional assays that one would typically use and the classic battery of safety profiles you do in neuro-drug discovery, such as ADME and PK. Then, we quickly test for the likelihood of hallucinogenic properties and an efficacy profile. So, weve got a range of multiple assays we assess so that as early as possible in the process, we can take some compounds off the assembly line that we feel are likely to display hallucinogenic properties and separate them from the non-hallucinogenic ones.

We dont allocate resources, time, or effort to the early-stage compounds weve developed and synthesized that have robust IP but are likely to be hallucinogenic. Over time, I feel those could be good candidates for other companies who are better natural owners and stewards of the hallucinatory approach. Thats not our lane, but we have identified and can build compounds that perhaps have an optimized hallucinatory profile.

The preclinical to clinical translatability is not great for hallucinatory properties. Some pretty good models like head twitch and related rodent models also have a pretty good R-square value for not being hallucinatory in man. We test efficacy through assays such as the non-forced four swim test, where we do the highest possible bar and most possible assays to demonstrate effectiveness in early-stage rodent models.

We also directly compare the compounds that we find most attractive against positive and negative controls. How are they doing against ketamine for being rapid-acting and long-lasting? We also dont want to develop another SSRI or something you must take daily. We want to be a once a month, twice a month, once every two months therapy, not once a day. Finally, we look at safety, toxicology, and dosing models that inform eventual clinical candidate selection and then patient subtypes.

GEN Edge: What is Delixs approach to funding?

Rus: The syndicate you build is essential, not just from the capital perspective. Its important to build with investors who truly understand neuro-drug development and are interested in building a leading neuroscience company, not short-term investors. And were fortunate to have that syndicate, having raised about a hundred million last year through our Series A and convertible note round. We have great teammates from ARTIS Ventures, RA Capital Management, founding investor OMX Ventures, and others.

GEN Edge: Whats on the horizon for Delix?

Rus: We want to get into the clinic to demonstrate human translatability for a Delix compound ASAP next year and continue to advance our pipeline candidates out of our platform, ready to move into IND-enabling studies adjacent to those clinical studies from phase one. We feel that being the leading non-hallucinatory, psychoplastogen company globally is a step towards being a leading neuroscience company by 2030.

Were building out our headquarters, and well be moving in next year here in Massachusetts in Q1. We couldnt be more thrilled to have a shot at making a big meaningful difference in something that all of us face one way or the othereither with ourselves, loved ones, or friendswith the suboptimal standard of care in mental health.

See the original post here:

What A Trip: Delix Therapeutics is Treating Mental Health at Scale with Psychoplastogens - Genetic Engineering & Biotechnology News

Posted in Psychedelics | Comments Off on What A Trip: Delix Therapeutics is Treating Mental Health at Scale with Psychoplastogens – Genetic Engineering & Biotechnology News